Hofmann C, Strauss M
HepaVec AG für Gentherapie, Berlin-Buch, Germany.
Gene Ther. 1998 Apr;5(4):531-6. doi: 10.1038/sj.gt.3300607.
Baculovirus vectors are efficient tools for gene transfer into hepatocytes in vitro. However, gene transfer is strongly reduced in the presence of native sera, providing an explanation for the failure of direct application of the virus in vivo. In this study, we define the role of the complement (C) system (C) as a major cause for baculovirus inactivation in human serum. Baculoviruses most likely activate the classical pathway of the C system and assembly of very late C components is required for inactivation of the vector. We demonstrate the survival of baculovirus vectors in human serum through treatment with a functional blocking antibody against C component 5. Inactivation of baculovirus in human plasma and whole blood was prevented by treatment with cobra venom factor. The data reveal various interactions of baculovirus vectors with the C system and will lead to facilitation of baculovirus-mediated gene transfer into hepatocytes in vivo by protection of the vector from C inactivation.
杆状病毒载体是体外将基因导入肝细胞的有效工具。然而,在天然血清存在的情况下,基因转移会显著减少,这为病毒在体内直接应用失败提供了解释。在本研究中,我们确定补体(C)系统是人类血清中杆状病毒失活的主要原因。杆状病毒很可能激活C系统的经典途径,并且载体失活需要非常晚期C成分的组装。我们通过用针对C成分5的功能性阻断抗体处理,证明了杆状病毒载体在人类血清中的存活。用眼镜蛇毒因子处理可防止杆状病毒在人血浆和全血中失活。这些数据揭示了杆状病毒载体与C系统的各种相互作用,并将通过保护载体免于C失活,促进杆状病毒介导的基因在体内导入肝细胞。